Analysts’ downgrades for Thursday, June 2nd: Aeglea BioTherapeutics (NASDAQ:AGLE) was downgraded by analysts at Piper Sandler from an overweight rating to a neutral rating. They currently have $1.00 price target on the stock, down from their previous price target of $4.00. C3.ai (NYSE:AI) was downgraded by analysts at Piper Sandler from an overweight rating to […]
Investment Analysts’ upgrades for Tuesday, May 31st: Amundi (OTCMKTS:AMDUF) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. Aperam (OTCMKTS:APEMY) was upgraded by analysts at Morgan Stanley from an equal weight rating to an overweight rating. China Gas (OTCMKTS:CGHLY) was upgraded by analysts at Daiwa Capital […]